What are the Main Differences Between MIS-C and Kawasaki Disease?
Discussion SARS-CoV-2 or COVID-19 was first observed in Wuhan China in late 2019. By March 2020 it had spread to become a world-wide pandemic and continues today despite vaccination and other public health measures. Early on people were worried that children would be the major age group affected, but the major groups were older individuals and those with underlying health problems. That is not to say that children are not affected as they were and could have severe disease. However as an overall group, they tend to get the virus and have less severe symptoms than adults. Severe disease is about 1% of pediatric cases compar...
Source: PediatricEducation.org - November 22, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

ADVOCATE: Avacopan Shows Renal Benefits in ANCA Vasculitis ADVOCATE: Avacopan Shows Renal Benefits in ANCA Vasculitis
The oral C5a receptor inhibitor could allow for the ' previously unthinkable ' avoidance of steroid treatment, and related adverse effects, in those with ANCA-associated vasculitis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2021 Category: Consumer Health News Tags: Nephrology News Source Type: news

FDA approves add-on drug for adults with rare form of blood vessel inflammation
FDA has approved Tavneos (avacopan) as an add-on treatment to standard therapy including glucocorticoids for adult patients with severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. Tavneos helps to reduce blood vessel inflammation and offers patients an additional t (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 13, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Nephrotic Syndrome and Vasculitis After SARS-CoV-2 Vaccine Nephrotic Syndrome and Vasculitis After SARS-CoV-2 Vaccine
Are reported cases of nephrotic syndrome and vasculitis associated with the administration of the COVID-19 vaccine?Nephrology Dialysis Transplantation (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 17, 2021 Category: Intensive Care Tags: Nephrology Journal Article Source Type: news

What Are the Advantages and Disadvantages of Different Renal Replacement Therapies?
Discussion Kidneys are amazing in that they filter the blood, eliminate toxins, balance fluids and electrolytes plus have a lot of reserve to do the job they need to do even when injured. Therefore, depending on the problem, chronic renal disease (CRD) often allows time before renal replacement therapy (RRT) is needed. RRT currently is dialysis (peritoneal or hemodialysis) or renal transplant. In general, the patient’s own kidneys do the best job for them but there is always a balance between the problems of CRD and its management, versus the potentially improved renal function with RRT. RRT itself though has a diffe...
Source: PediatricEducation.org - September 13, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

How Do You Treat Immersion Foot Injury?
Discussion All occupations have some type of potential health consequences. Some are obvious because of the environment such as kitchen workers, first responders, helicopter pilots, etc. Others are may be less obvious or not considered such as slip and falls, cleaning supply chemical exposure, animal bites for postal and utility workers, etc. Noise and lifting objects are often overlooked problems in some settings but obvious in others such as construction. Protective measures, especially appropriate education and training and protective clothing and safety gear are obviously important for performing the work as safely as ...
Source: PediatricEducation.org - July 26, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Three New Drugs Implicated in ANCA-Associated Vasculitis Three New Drugs Implicated in ANCA-Associated Vasculitis
Mirabegron, sofosbuvir, and nintedanib join a list of 12 other drugs that have been linked to an overreporting of drug-associated ANCA vasculitis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 16, 2021 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news

New ACR Guidelines Give Advice on Six Forms of Vasculitis New ACR Guidelines Give Advice on Six Forms of Vasculitis
Nearly all recommendations made for giant cell arteritis, Takayasu arteritis, polyarteritis nodosa, and three forms of ANCA-associated vasculitis are conditional rather than strong.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 16, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news

ACR/Vasculitis Foundation release three new guidelines for treatment of vasculitis
(American College of Rheumatology) The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released three new guidelines for the treatment and management of systemic vasculitis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2021 Category: International Medicine & Public Health Source Type: news

Lower Steroid Dose Proves Effective for New-Onset ANCA Vasculitis Lower Steroid Dose Proves Effective for New-Onset ANCA Vasculitis
An open-label, randomized trial found that a reduced dose of glucocorticoids added to standard induction therapy with rituximab was safer and no worse than a higher dose at maintaining remission.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 1, 2021 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news

Antibiotic Cut ANCA-Vasculitis Infection Risk With Rituximab Antibiotic Cut ANCA-Vasculitis Infection Risk With Rituximab
Co-use of cotrimoxazole decreased the risk for infection, which remains high in patients with vasculitis who are treated with rituximab.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 7, 2021 Category: Consumer Health News Tags: Rheumatology News Source Type: news

FDA Panel Narrowly Backs Avacopan Approval FDA Panel Narrowly Backs Avacopan Approval
The FDA is mulling whether to approve avacopan for ANCA-associated vasculitis largely on the basis of a single trial about which the agency staff has concerns.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 7, 2021 Category: Consumer Health News Tags: Rheumatology News Source Type: news

B Cells in Relapsing Lupus Nephritis and Cutaneous Vasculitis B Cells in Relapsing Lupus Nephritis and Cutaneous Vasculitis
A case of a woman with systemic lupus erythematosus whose nephritis and cutaneous vasculitis were refractory to treatment.HSS Grand Rounds Complex Cases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 28, 2021 Category: Consumer Health News Tags: Rheumatology Clinical Case Source Type: news

Avacopan Noninferior to Prednisone for ANCA - Associated Vasculitis
Avacopan noninferior to prednisone taper for remission at week 26, superior to prednisone taper for sustained remission at week 52 (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 18, 2021 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Nephrology, Oncology, Pharmacy, Rheumatology, Journal, Source Type: news

Avacopan Noninferior to Prednisone for ANCA-Associated Vasculitis
THURSDAY, Feb. 18, 2021 -- Avacopan is noninferior, but not superior, to prednisone with respect to remission at week 26 for patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, according to a study published in the Feb.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 18, 2021 Category: Pharmaceuticals Source Type: news